Clinical trial, phase IIIb, multicentre double-blind, to evaluate the efficacy of vardenafil orodispersible vs placebo in patients with erectile dysfunction and comorbidities and the impact on quality of life of sexual partners [ENSAYO CLINICO, FASE IIIb, MULTICENTRICO, DOBLE CIEGO, PARA EVALUAR LA EFICACIA DE VARDENAFILO BUCODISPERSABLE vs PLACEBO, EN PACIENTES CON DISFUNCION ERECTIL MAS COMORBILIDAD Y EL IMPACTO EN LA CALIDAD DE VIDA SEXUAL DE SU PAREJA]

Trial Profile

Clinical trial, phase IIIb, multicentre double-blind, to evaluate the efficacy of vardenafil orodispersible vs placebo in patients with erectile dysfunction and comorbidities and the impact on quality of life of sexual partners [ENSAYO CLINICO, FASE IIIb, MULTICENTRICO, DOBLE CIEGO, PARA EVALUAR LA EFICACIA DE VARDENAFILO BUCODISPERSABLE vs PLACEBO, EN PACIENTES CON DISFUNCION ERECTIL MAS COMORBILIDAD Y EL IMPACTO EN LA CALIDAD DE VIDA SEXUAL DE SU PAREJA]

Completed
Phase of Trial: Phase III

Latest Information Update: 01 Jun 2014

At a glance

  • Drugs Vardenafil (Primary)
  • Indications Erectile dysfunction
  • Focus Therapeutic Use
  • Acronyms VADEOPEN
  • Most Recent Events

    • 22 Jun 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top